Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × capivasertib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Leukemia 2 Healthy Participants 2 Endometrial Neoplasms 2 Disease Progression 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Moderate Hepatic Impairment 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Meningioma 1 Lymphoma 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Exanthema 1 Estrogen Receptor Positive Breast Cancer 1 Diarrhea 1 Chondrosarcoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 CCCA Assessed by Ki67 Drop Below <2.7% From Baseline 1

Interventions

Rituximab 47 Cyclophosphamide 38 ibrutinib 22 fludarabine 22 acalabrutinib 20 venetoclax 18 Bendamustine Hydrochloride 18 zanubrutinib 15 Lenalidomide 15 CT-P10 13 fludarabine phosphate 12 Cytarabine 12 pirtobrutinib 11 obinutuzumab 11 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Etoposide 9 Vincristine 8 Doxorubicin 8 Biopsy 8 glofitamab 7 Whole-Body Irradiation 7 Mycophenolic Acid 6 Methotrexate 6 Melphalan 6 Peripheral Blood Stem Cell Transplantation 5 Immunotherapy, Adoptive 5 Cyclosporine 5 orelabrutinib 4 brexucabtagene autoleucel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡